LifeStance Health Group Inc. (LFST)
NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LFST stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.25B
- P/E (TTM)
- 76.78
- Forward P/E
- 30.77
- EPS (TTM)
- $0.18
- Dividend yield
- None
- 52-week range
- 6.21 – 15.66
- Day range
- 13.21 – 13.83
- Volume / Avg
- 5.62M / 5.27M
- Beta
- —
- Shares outstanding
- 380.19M
52-week range
LFST stock today
LifeStance Health Group (LFST) closed at $13.82 on Nov 20, up 3.60% (+$0.48), versus the S&P 500's 3.70% decline. Shares are 11.7% below their 52-week high of $15.66, set on Nov 5, 2026 and 122.7% above the 52-week low of $6.21, near the top of the past year's range. LFST is up 96.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 114.6%.
At 76.8x trailing earnings, LifeStance Health Group trades above the peer-group median of 22.9x. Its forward P/E of 30.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About LifeStance Health Group
Company profileLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. David Patrick Bourdon
- Headquarters
- Scottsdale, AZ
- Employees
- 8,863
- IPO year
- 2021
- Website
- lifestance.com
Financial highlights
Full financialsIn fiscal 2025, LifeStance Health Group generated $1.42 billion in revenue, up 13.9% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $9.7 million, for a net margin of 0.7% versus a median of -17.6% in the prior 5 years. Operating margin was 1.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.54M | $667.51M |
| Growth | +13.85% | +18.50% | +22.82% | +28.77% | +214.10% |
| Net income | $9.66M | $-57.44M | $-186.26M | $-215.56M | $-307.20M |
| EPS (diluted) | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
Analyst forecast
ForecastConsensus (11 analysts)
buy
Avg. price target
$16.80+21.56%
- Strong buy 2
- Buy 7
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.06 vs $0.03
- Surprise
- +100.00%
LFST news
All LFST news- IDEF, FMED: Big ETF OutflowsNasdaqIDEF, RTX, LMT, TXG
- LifeStance Health Prices Secondary Offering Of 45 Mln Shares At $13.12/ShrNasdaqLFST, HEI.A
- LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/ShrNasdaq
- LifeStance Health Group Announces Pricing of Secondary Public OfferingGlobeNewswire
- LifeStance Health Group Announces Launch of Secondary Public OfferingGlobeNewswire
- Consensus Price Target for LifeStance Health Group Increased by 13.36% to $16.01Nasdaq
- LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run?NasdaqLFST, EHC
- LifeStance (LFST) Q3 2026 Earnings Call TranscriptNasdaq
LifeStance Health Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OPCHOption Care Health Inc. | 31.59 | -0.06% | $4.73B | vs LFST |
| HIMSHims & Hers Health Inc. Class A | 14.60 | -8.86% | $3.42B | vs LFST |
| CHEChemed Corp | 548.59 | -0.50% | $7.11B | vs LFST |
| PRVAPrivia Health Group Inc. | 25.05 | +1.46% | $3.20B | vs LFST |
| AVAHAveanna Healthcare Holdings Inc. | 11.01 | +2.90% | $2.40B | vs LFST |
| ADUSAddus HomeCare Corporation | 122.50 | +1.18% | $2.28B | vs LFST |
| USPHU.S. Physical Therapy Inc. | 95.93 | +1.71% | $1.43B | vs LFST |
| WGSGeneDx Holdings Corp. Class A | 45.46 | -7.68% | $1.36B | vs LFST |
Indexes, lists and sector
LifeStance Health Group stock FAQ
What is LifeStance Health Group's stock price today?
LFST last traded at $13.82 as of Nov 20, 4:00 PM EST, up 3.60% on the day. Prices are delayed at least 15 minutes.
What is LFST's P/E ratio?
LFST trades at a trailing P/E ratio of 76.78 and a forward P/E of 30.77, compared with a median of 22.9 for its closest peers.
Who is LifeStance Health Group's CEO?
Mr. David Patrick Bourdon is the chief executive officer of LifeStance Health Group Inc., which has about 8,863 employees.
What is the LFST 52-week high?
The 52-week high for LFST is $15.66 and the 52-week low is $6.21. The stock is currently 11.7% below its high.